Latest Breaking News On - Maher masoud - Page 1 : comparemela.com

MaxCyte, Inc. (NASDAQ:MXCT – Get Free Report) CEO Maher Masoud acquired 70,443 shares of the stock in a transaction dated Monday, June 10th. The stock was bought at an average cost of $4.90 per share, with a total value of $345,170.70. Following the completion of the purchase, the chief executive officer now owns 100,000 shares […]

United statesMaher masoudWilliam blairPricet rowe associates incMaxcyte company profileMaxcyte incRoubaix capitalLazard asset managementSilvercrest asset management groupGet free reportAsset management groupAsset managementMaxcyte daily